NCT05862103 Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort
| NCT ID | NCT05862103 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yu Bo |
| Condition | Acute Myocardial Infarction |
| Study Type | OBSERVATIONAL |
| Enrollment | 15,000 participants |
| Start Date | 2022-12-21 |
| Primary Completion | 2025-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 15,000 participants in total. It began in 2022-12-21 with a primary completion date of 2025-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
AMI Survivors who participated in the project "Construction and key technology research of the whole myocardial protection system for acute myocardial infarction" (project number 2016YFC1301100) and completed the 1-year visit were followed up by telephone at 3 years (within the corresponding follow-up time window) and 5 years after discharge to acquire the patients' medication, health status, and major adverse cardiovascular and cerebrovascular events, including death, heart failure, rehospitalization, re-myocardial infarction, revascularization, stroke, malignant arrhythmia, and bleeding events.
Eligibility Criteria
Inclusion Criteria: * AMI survivors who participated in the project "Construction and key technology research of the whole myocardial protection system for acute myocardial infarction" and completed the 1-year visit. * Telephone to obtain informed consent from the subjects/family members of the subjects. Exclusion Criteria: * Not available
Contact & Investigator
Bo Yu
STUDY CHAIR
The Second Affiliated Hospital of Harbin Medical University
Frequently Asked Questions
Who can join the NCT05862103 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Myocardial Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05862103 currently recruiting?
Yes, NCT05862103 is actively recruiting participants. Contact the research team at xlzhangdr@163.com for enrollment information.
Where is the NCT05862103 trial being conducted?
This trial is being conducted at Beijing, China, Beijing, China, Beijing, China, Guangzhou, China and 11 additional locations.
Who is sponsoring the NCT05862103 clinical trial?
NCT05862103 is sponsored by Yu Bo. The principal investigator is Bo Yu at The Second Affiliated Hospital of Harbin Medical University. The trial plans to enroll 15,000 participants.